Personally, Bash on Ubuntu on Windows is a fine solution for my most common use cases.

I think the most egregious example is latter seasons of The Big Bang Theory clocking in at 16 minutes. That's ~50% ads.

In the case of vaccines specifically, there is just a surprising amount of things we still don't understand.

Vaccination is positively ancient technology (Smallpox circa 1796), but it is still difficult to say why e.g., some vaccines are broadly effective at producing immunity and some aren't (and what the factors at play are in the recipients), or why we can produce successful vaccines to some diseases and not others.

A specific example: the efficacy of BCG vaccination (tuberculosis) varies by manufacturer and the reasons for why that is are still unclear.

There are a number of large NIH-funded initiatives that aim at understanding the complex cellular and molecular interactions that result in immunity as a result of vaccination under the Human Immunology Project Consortium (a bunch of high profile papers in Cell, etc. over the past few years).

> There is so much money circulating in private markets, but employees just can't access it. This seems pretty unfair to me.

Isn't this almost certainly by design?

I haven't looked into their new minion much yet, but how cheap are really talking about?

Originated in the 'magrittr' package. The early tidyverse used a different pipe before depending on magrittr's version.

Not to mention 'tweaking' required.

I bought directly and was passed around by Google and Huawei support for months (and multiple calls; hours of my time wasted - why can't anyone just do support by email anymore?) before ultimately giving up on getting the constant battery issues addressed. Initial contact was precisely 3 weeks outside of the warranty period for the now well-documented phone shuts off when battery reaches [15|30|50]%.

I feel like I purchased a year's worth of problem-free phone experience for nearly $CAD900. To me, that's not great value.

> Is this "grammar of graphics" any good if you invest more time in it?

For some, it was probably one of THE things that kept them using R over something else. Yes, definitely worth it.

Overemphasis on commercialization is a common complaint of the current funding situation in medical research, so I don't think we're failing for lack of interest in commercial exits. In fact, many scientist are serial entrepreneurs.

Moreover, many discoveries that went on to make a lot of people a lot of money had no obvious commercial application when they were first being researched... Predicting future markets is hard.

No I don't mean "made money", that would just be standard venture capital.

I mean "achieves their targets by reducing the total burden of disease on humanity", which is a different radical exit.

I'm afraid I don't quite understand what you mean by "achieves their targets by reducing the total burden of disease on humanity". Or maybe I just don't understand the difference between this as merely "achieves their targets by selling useful treatments to people"?

Could to elaborate?

A malaria vaccine would make no commercial sense but would be a huge reduction in the total burden of disease. That's what I mean.